Assessing the timing of invasive intervention in NSTE-ACS: insights from a meta-analysis and sequential trial evaluation
For patients with NSTE-ACS, early invasive treatment does not reduce all-cause mortality or incidence of MI but is associated with a lower frequency of recurrent ischemia.
Authors
- Chonghui Wang (ORCID: https://orcid.org/0000-0002-8753-7518)
- Wei Yang (ORCID: https://orcid.org/0000-0001-5126-3415)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- China Rehabilitation Research Center (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-11-20
- DOI
- https://doi.org/10.3389/fcvm.2025.1712137
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00